
1. aids res ther. 2005 oct 11;2:9.

human immunodeficiency virus type-1 episomal cdna semen.

xu c(1), politch ja, mayer kh, anderson dj.

author information: 
(1)division reproductive biology, department obstetrics gynecology,
boston university school medicine, boston, 02118, usa. chong.xu@bmc.org

background: episomal 2-long terminal repeat (ltr) hiv-1 cdna, by-product of
hiv-1 infection, used clinical trials marker ongoing viral
replication. would useful employ 2-ltr cdna monitor cryptic hiv-1
infection genital tract men antiretroviral therapy (art) predict 
the evolution sexually transmissible drug-resistant hiv-1, studies thus
far failed detect marker semen. objectives study
were: 1) use technique maximizes dna recovery hiv-1 infected white
blood cells semen determine episomal 2-ltr cdna detectable semen
of art-naïve men evidence genital tract hiv-1 infection, 2) 
compare levels hiv-1 2-ltr cdna, rna, proviral dna semen hiv-1+
men art.
results: using somatic cell dna extraction technique, 2-ltr cdna detected
by pcr/elisa 4 8 semen samples art-naïve men selected other
signs seminal hiv-1 infection (positive controls). southern blot dna
sequencing confirmed amplified sequences hiv-1 2-ltr cdna; copy
numbers ranged 55 504 copies/sample. two semen samples cohort of
22 hiv-1-infected men dual nucleoside therapy, one one without
detectable seminal hiv-1 rna, 2-ltr cdna positive (336 8,560
copies/sample). following addition indinavir therapy regimen, semen 
samples 21 men controlled peripheral seminal viral loads 2-ltr
cdna positive 1 6 month time points, despite persistence hiv-1
proviral dna+ semen cells seminal cytomegalovirus (cmv) shedding some
cases. however, one individual failed indinavir therapy later developed
distinct protease inhibitor (pi) drug resistance mutations semen, maintained
elevated levels hiv-1 rna 2-ltr cdna semen.
conclusion: 2-ltr hiv-1 cdna detectable semen hiv-1-infected men. two
men art 2-ltr hiv-1 cdna semen, suggesting marker may prove
to useful monitor hiv-1 infection genital tract men art to
predict evolution drug resistance mutations semen.

doi: 10.1186/1742-6405-2-9 
pmcid: pmc1277815
pmid: 16219101 

